Cystic Fibrosis
"Cystic Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Descriptor ID |
D003550
|
| MeSH Number(s) |
C06.689.202 C08.381.187 C16.320.190 C16.614.213
|
| Concept/Terms |
Pancreatic Cystic Fibrosis- Pancreatic Cystic Fibrosis
- Cystic Fibrosis, Pancreatic
- Fibrocystic Disease of Pancreas
- Pancreas Fibrocystic Disease
- Pancreas Fibrocystic Diseases
- Cystic Fibrosis of Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Cystic Fibrosis".
Below are MeSH descriptors whose meaning is more specific than "Cystic Fibrosis".
This graph shows the total number of publications written about "Cystic Fibrosis" by people in this website by year, and whether "Cystic Fibrosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 1 | 5 | | 1997 | 3 | 1 | 4 | | 1998 | 4 | 1 | 5 | | 1999 | 3 | 1 | 4 | | 2000 | 4 | 0 | 4 | | 2001 | 4 | 2 | 6 | | 2002 | 12 | 0 | 12 | | 2003 | 7 | 0 | 7 | | 2004 | 13 | 0 | 13 | | 2005 | 15 | 4 | 19 | | 2006 | 13 | 3 | 16 | | 2007 | 22 | 1 | 23 | | 2008 | 13 | 3 | 16 | | 2009 | 18 | 1 | 19 | | 2010 | 20 | 3 | 23 | | 2011 | 14 | 1 | 15 | | 2012 | 17 | 1 | 18 | | 2013 | 3 | 2 | 5 | | 2014 | 21 | 3 | 24 | | 2015 | 25 | 0 | 25 | | 2016 | 28 | 1 | 29 | | 2017 | 22 | 1 | 23 | | 2018 | 29 | 4 | 33 | | 2019 | 32 | 1 | 33 | | 2020 | 41 | 0 | 41 | | 2021 | 53 | 2 | 55 | | 2022 | 52 | 0 | 52 | | 2023 | 58 | 0 | 58 | | 2024 | 32 | 4 | 36 | | 2025 | 43 | 1 | 44 | | 2026 | 16 | 2 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Cystic Fibrosis" by people in Profiles.
-
Calton MA, Croze RH, Sullivan TH, Collins SA, Tucker S, Whittlesey KJ, Kim DH, Nye JA, Beliakoff G, Quezada M, Burns C, Schmitt C, Klein A, Jia V, Kovacs L, Lauko D, Yoh K, Nguyen K, Barglow K, Gonzales J, Khoday D, Mason T, Delaria K, Bashour K, Kotterman M, Schaffer D, Song A, Francis P, Taylor-Cousar JL, Kirn D. Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease. Am J Respir Cell Mol Biol. 2026 Jul 01; 74(7):837-846.
-
Chalamalla AR, Baker E, Ryan KJ, Dowell A, Natt JR, Zemanick ET, Konstan MW, Mayer-Hamblett N, Acosta EP, Guimbellot JS. Impact of CFTR modulator concentrations on clinical response in cystic fibrosis. Eur Respir J. 2026 Jun; 67(6).
-
Leigh MW, Shapiro AJ, Chawla KK, Hazucha MJ, Brown DE, Lin FC, Jiang L, Carson JL, Davis SD, Dell SD, Sagel SD, Rosenfeld M, Milla C, Sullivan KM, Zariwala MA, Ferkol TW, Knowles MR. Tidal breathing nasal nitric oxide measurement as a test for primary ciliary dyskinesia in young children. Eur Respir J. 2026 Jun; 67(6).
-
Muther EF, Gibson SL, Ford C, Duncan C, Riekert KA, Lyons E, Hoppe JE, Prickett M, Isenburg MV, Everhart RS. People with cystic fibrosis' experience of symptom burden while taking elexacaftor/tezacaftor/ivacaftor. Respir Med. 2026 Aug; 259:108908.
-
Dunham SJB, Willkeen GA, Darby B, Corley JM, Hahn A, Klapper I, Bean HD, Caverly LJ, Thornton CS, Martin C, Quinn RA, Widder S, Bailey BA, Wagner BD, Garg N, Planet PJ, Hunter RC, LiPuma JJ, Rohwer F, Whiteson KL. The Guild Model of CF Airway Microbial Ecology. mBio. 2026 Jun 10; 17(6):e0366825.
-
Zemanick ET, Somayaji R. Clearing the Air: Rethinking Airway Infection With CFTR Modulators. J Infect Dis. 2026 04 29; 233(4):628-630.
-
Khan FN, Magaret A, Hsu C, Jain R, West NM, Taylor-Cousar JL, Roe AH, Uluer A, Bray LA, Godfrey EM. Association of CFRD development among females with CF who use hormonal contraception. J Cyst Fibros. 2026 May; 25(3):482-488.
-
Fought MK, Hong G, Quinn AC, Wagner BD, Robertson CE, Harris JK, Laguna TA. Molecular Methods to Detect and Quantify Fungal Communities in Cystic Fibrosis Airway Specimens. Pediatr Pulmonol. 2026 Apr; 61(4):e71598.
-
Kroes S, Taylor-Cousar JL, Zampoli M, Karadag B, van der Ent CK, de Winter-de Groot KM, Beekman JM, Spelier S. Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape. Pediatr Pulmonol. 2026 Apr; 61(4):e71584.
-
Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P. Decoding liver injury in cystic fibrosis: How to tell drug-induced liver injury from cystic fibrosis liver disease. World J Gastroenterol. 2026 Mar 14; 32(10):114946.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|